Skip to main content

Table 2 Hospitalization outcomes before and after propensity-score matching

From: Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data

 

Before propensity-score matching1

After propensity-score matching1

Characteristic

Cases

Non-Cases

Pvalue2

Mean

SE

Cases

Non-Cases

Pvalue2

Mean

SE

N (unweighted)

1,120

29,759,178

   

1,084

3,252

   

N (weighted)

5,515

146,295,097

   

5,346

15,999

   

Length of stay (days)

          

 Mean (SD)

24.5 (32.0)

5.8 (8.3)

< 0.001

18.6

0.4

24.5 (31.9)

8.0 (11.9)

< 0.001

16.5

0.4

 Median (IQR)

14 (6–30)

4 (2–7)

   

14 (6–30)

4 (2–9)

   

Mortality (%)

22.2%

3.6%

< 0.001

18.7%

0.6%

22.1%

4.4%

< 0.001

17.7%

0.6%

Discharge type among survivors (%)

  

< 0.001

    

< 0.001

  

 Routine

46.0%

63.3%

   

46.0%

69.9%

   

 Short-term hospital

9.6%

2.5%

   

9.7%

1.8%

   

 Other transfers3

18.5%

19.3%

   

18.8%

12.3%

   

 Home health care

24.8%

14.0%

   

24.3%

14.8%

   

 Other/unknown

1.1%

0.9%

   

1.2%

1.1%

   

Total Charges

          

 Mean (SD)

$237,090 ($283,375)

$44,442 ($69,052)

< 0.001

$192,648

$3,816

$237,114 ($285,769)

$71,698 ($114,452)

< 0.001

$165,417

$4,012

 Median (IQR)

$128,682

$25,423

   

$127,171

$33,958

   

($48,025 - $303,348)

($13,423 - $48,779)

   

($47,653-$301,540)

($17,241 -$74,044)

   

Total Costs

          

 Mean (SD)

$90,107 ($111,760)

$16,582 ($24,509)

< 0.001

$73,525

$1,505

$90,272 ($112,964)

$25,746 ($41,207)

< 0.001

$64,526

$1,579

 Median (IQR)

$51,170

$9,943

   

$51,004

$12,327

   

($17,869 - $112,910)

($5,518 - $18,392)

   

($17,256 -$112,928)

($6,531 - $27,424)

   
  1. Source: HCUP 2003–2010.
  2. [1] Non-mucormycosis hospitalizations from hospitals with at least one mucormycosis patient are matched 3:1 to mucormycosis hospitalizations using a greedy 8 to 1 digit matching algorithm.
  3. [2] Significance was tested for proportions using the Rao-Scott Chi-Square Test. Continuous measures were tested using an independent sample t-test.
  4. [3] Includes skilled nursing facility, intermediate care, and any other type of facility.
  5. Note: Charges and costs reported in 2011 USD.